Loading...
NeuroSense Therapeutics Ltd.
NRSN•NASDAQ
HealthcareBiotechnology
$1.79
$0.07(4.07%)
NeuroSense Therapeutics Ltd. (NRSN) Quarterly Earnings Reports & Financial Results
Analyze NeuroSense Therapeutics Ltd.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of NeuroSense Therapeutics Ltd.’s actual vs. estimated earnings across recent quarters.
No data available
NeuroSense Therapeutics Ltd. (NRSN) Quarterly Earnings Details
Detailed breakdown of NeuroSense Therapeutics Ltd.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.